Related Experiment Video
Updated: Jun 9, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition
Elizabeth A Barnes1, Heidi L Kenerson, Xiuyun Jiang
1Department of Surgery, University of Washington, Seattle, Washington 98195, USA.
Abstract:
The tuberous sclerosis complex 2 (TSC2) gene encodes the protein tuberin, which functions as a key negative regulator of both mammalian target of rapamycin (mTOR) C1-dependent cell growth and proliferation. Loss-of-function mutations of TSC2 result in mTORC1 hyperactivity and predispose individuals to both tuberous sclerosis and lymphangioleiomyomatosis. These overlapping diseases have in common the abnormal proliferation of smooth muscle-like cells. Although the origin of these cells is unknown, accumulating evidence suggests that a metastatic mechanism may be involved, but the means by which the mTOR pathway contributes to this disease process remain poorly understood. In this study, we show that tuberin regulates the localization of E-cadherin via an Akt/mTORC1/CLIP170-dependent, rapamycin-sensitive pathway. Consequently, Tsc2(-/-) epithelial cells display a loss of plasma membrane E-cadherin that leads to reduced cell-cell adhesion. Under confluent conditions, these cells detach, grow in suspension, and undergo epithelial-mesenchymal transition (EMT) that is marked by reduced expression levels of both E-cadherin and occludin and increased expression levels of both Snail and smooth muscle actin. Functionally, the Tsc2(-/-) cells demonstrate anchorage-independent growth, cell scattering, and anoikis resistance. Human renal angiomyolipomas and lymphangioleiomyomatosis also express markers of EMT and exhibit an invasive phenotype that can be interpreted as consistent with EMT. Together, these results suggest a novel relationship between TSC2/mTORC1 and the E-cadherin pathways and implicate EMT in the pathogenesis of tuberous sclerosis complex-related diseases.
Insights
Loss of the TSC2 gene causes abnormal cell growth in tuberous sclerosis and lymphangioleiomyomatosis. This study reveals TSC2 regulates E-cadherin, impacting cell adhesion and promoting epithelial-mesenchymal transition (EMT) in these diseases.
Area of Science:
- Cell Biology
- Genetics
- Oncology
Background:
- Tuberous sclerosis complex 2 (TSC2) encodes tuberin, a negative regulator of mammalian target of rapamycin (mTOR) C1 signaling.
- Loss-of-function mutations in TSC2 lead to mTORC1 hyperactivity, causing tuberous sclerosis and lymphangioleiomyomatosis, characterized by smooth muscle-like cell proliferation.
- The metastatic potential and the role of the mTOR pathway in these diseases are not fully understood.
Purpose of the Study:
- To investigate the role of tuberin in regulating cell adhesion and epithelial-mesenchymal transition (EMT).
- To elucidate the mechanism by which the TSC2/mTORC1 pathway influences E-cadherin localization and cell behavior.
Main Methods:
- Utilized Tsc2(-/-) epithelial cells to study E-cadherin regulation and EMT.
- Analyzed cell-cell adhesion, plasma membrane E-cadherin levels, and expression of EMT markers (E-cadherin, occludin, Snail, smooth muscle actin).
- Assessed functional changes including anchorage-independent growth, cell scattering, and anoikis resistance. Examined human disease tissues for EMT markers.
Main Results:
- Tuberin regulates E-cadherin localization through an Akt/mTORC1/CLIP170 pathway.
- Tsc2(-/-) cells exhibit reduced E-cadherin at the plasma membrane, leading to decreased cell adhesion.
- These cells undergo EMT, characterized by altered expression of adhesion molecules and EMT markers, and display anchorage-independent growth, scattering, and anoikis resistance.
- Human angiomyolipomas and lymphangioleiomyomatosis tissues show EMT markers and invasive phenotypes.
Conclusions:
- TSC2/mTORC1 signaling is intricately linked with E-cadherin regulation.
- EMT is implicated as a key mechanism in the pathogenesis of tuberous sclerosis complex-related diseases.
- This study provides novel insights into the cellular mechanisms driving these conditions and suggests potential therapeutic targets.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin homology) domains...
Assembly of Complex Microtubule Structures
Regulation of Angiogenesis and Blood Supply
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...

